NCT05067426

Brief Summary

A randomized, controlled trial to evaluate the effects of two versions of 10 high intensity interval trainings (HIIT) within a 7-day shock microcycle on endurance performance, well-being, health, stress and recovery in trained athletes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started Aug 2021

Typical duration for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 15, 2021

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

September 6, 2021

Completed
29 days until next milestone

First Posted

Study publicly available on registry

October 5, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

January 31, 2024

Status Verified

January 1, 2024

Enrollment Period

1.4 years

First QC Date

September 6, 2021

Last Update Submit

January 30, 2024

Conditions

Keywords

High-intensity interval trainingMicrocycleEndurance trainingLoad monitoringAthlete performanceHIT trainingBlock trainingHIT blockPolarized training

Outcome Measures

Primary Outcomes (6)

  • Endurance performance I

    Change of maximal oxygen uptake (VO2max in ml/min/kg) compared to baseline and group

    10 to 21 days (assessment is conducted once before the intervention and repeated three times afterwards, i.e. 3, 7 and 14 days after the completion of the intervention)

  • Endurance performance II

    Change of peak performance (Ppeak in Watt) compared to baseline and group

    10 to 21 days (assessment is conducted once before the intervention and repeated three times afterwards, i.e. 3, 7 and 14 days after the completion of the intervention)

  • Endurance performance III

    Change of 5 kilometer time trial performance (in sec) compared to baseline and group

    20 to 22 days (the assessment is conducted once before, and once after the intervention)

  • Endurance performance IV

    Change of lactate threshold (in km/h) compared to baseline and group

    10 to 21 days (assessment is conducted once before the intervention and repeated three times afterwards, i.e. 3, 7 and 14 days after the completion of the intervention)

  • Endurance performance V

    Change of ventilatory thresholds (in km/h) compared to baseline and group

    10 to 21 days (assessment is conducted once before the intervention and repeated three times afterwards, i.e. 3, 7 and 14 days after the completion of the intervention)

  • Endurance performance VI

    Change of running economy (in ml/min/kg) compared to baseline and group

    10 to 21 days (assessment is conducted once before the intervention and repeated three times afterwards, i.e. 3, 7 and 14 days after the completion of the intervention)

Secondary Outcomes (27)

  • Change of questionnaire scores - well-being

    30 days (questionnaires will be given to participants several times before, during, and after the intervention.)

  • Change of questionnaire scores - muscular fatigue

    30 days (questionnaires will be given to participants several times before, during, and after the intervention.)

  • Change of questionnaire scores - vitality

    30 days (questionnaires will be given to participants several times before, during, and after the intervention.)

  • Change of questionnaire scores - rate of fatigue

    30 days (questionnaires will be given to participants several times before, during, and after the intervention.)

  • Change of questionnaire scores - sleep quality

    30 days (questionnaires will be given to participants several times before, during, and after the intervention.)

  • +22 more secondary outcomes

Study Arms (3)

HIIT-HV

EXPERIMENTAL

HIIT-HV - high intensity interval training high volume Participants complete a total of 10 HIIT sessions over a 7-day period consisting of 5 x 4-minute intervals at an intensity of 90-95% of their individual maximum heart rate (HRmax), interspersed with a 2.5-minute active recovery period. Each training session is followed by 30 minutes of low-intensity training (total of 300 minutes of additional low-intensity training during this period).

Other: Exercise

HIIT-LV

EXPERIMENTAL

HIIT- LV - high intensity interval training low volume Participants complete a total of 10 HIIT sessions over a 7-day period consisting of 5 x 4-minute intervals at an intensity of 90-95% of their individual maximum heart rate (HRmax), interspersed with a 2.5-minute active recovery period.

Other: Exercise

Control group

NO INTERVENTION

Participants continue with their regular training program.

Interventions

high-intensity interval training sessions

HIIT-HVHIIT-LV

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Female or male
  • aged 18-45 years
  • Proof of physical fitness (e.g. sports medical examination required) for measurements with higher intensities (e.g. endurance tests, competition simulation)
  • Competition experience at the national or international level in an endurance sport
  • VO2max ≥50ml/kg/min for females; ≥55 ml/kg/min for males or a 5-kilometer (km) time trial performance of ≤ 20:00 min (female), or ≤ 18:30 min (male)

You may not qualify if:

  • Systemic disease or other known pathology in the organs: heart, lungs, kidney, stomach, spleen, liver, gall bladder, and intestines.
  • Evidence of pulmonary disease: forced expiratory volume in one second/forced expiratory volume \< 70% with/without symptoms (cough, sputum) or other evidence of pulmonologic disease.
  • Diabetes II.
  • Neurological or psychological disease of any kind.
  • Currently undergoing medical or psycho-therapeutic treatment.
  • Health condition that does not allow regular participation in the training forms (e.g. acute illnesses such as fever or other flu-like infections within the last 7 days before the start of the study), orthopedic diseases, injuries to the muscular, bone, joint or tendon apparatus within the last three months.
  • Alcohol or drug abuse.
  • Already high training volume with high intensity training (more than 2 weekly training sessions of high-intensity training)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Salzburg

Salzburg, 5400, Austria

Location

Related Publications (4)

  • Tomaskovic A, Strepp T, Stoggl TL, Neuberger EWI, Simon P, Haller N. Acute and Chronic Effects of a High-Intensity Interval Training Shock Microcycle on Cell-Free DNA: A Randomized Controlled Trial. Sports Med Open. 2025 Nov 21;11(1):132. doi: 10.1186/s40798-025-00923-9.

  • Strepp T, Blumkaitis JC, Sareban M, Stoggl TL, Haller N. Training Intensity Distribution of a 7-Day HIIT Shock Microcycle: Is Time in the "Red Zone" Crucial for Maximizing Endurance Performance? A Randomized Controlled Trial. Sports Med Open. 2024 Sep 5;10(1):97. doi: 10.1186/s40798-024-00761-1.

  • Strepp T, Blumkaitis JC, Haller N, Stoggl TL. Adding LIT to HIIT: Is Low-Intensity Training Vital for Endurance-Trained Athletes during a 7-day HIIT Shock Microcycle? Med Sci Sports Exerc. 2024 Aug 1;56(8):1408-1421. doi: 10.1249/MSS.0000000000003435. Epub 2024 Apr 6.

  • Stoggl TL, Blumkaitis JC, Strepp T, Sareban M, Simon P, Neuberger EWI, Finkenzeller T, Nunes N, Aglas L, Haller N. The Salzburg 10/7 HIIT shock cycle study: the effects of a 7-day high-intensity interval training shock microcycle with or without additional low-intensity training on endurance performance, well-being, stress and recovery in endurance trained athletes-study protocol of a randomized controlled trial. BMC Sports Sci Med Rehabil. 2022 May 7;14(1):84. doi: 10.1186/s13102-022-00456-8.

MeSH Terms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Thomas Stoeggl, Professor, PhD

    University of Salzburg

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are randomly assigned in either one of 2 intervention groups or a control group (ratio 1:1:1).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Researcher

Study Record Dates

First Submitted

September 6, 2021

First Posted

October 5, 2021

Study Start

August 15, 2021

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

January 31, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations